Bank of America Corp DE reduced its stake in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 6.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 102,726 shares of the medical device company’s stock after selling 6,897 shares during the period. Bank of America Corp DE owned about 0.21% of Cooper Companies, Inc. (The) worth $20,533,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in COO. YorkBridge Wealth Partners LLC raised its position in shares of Cooper Companies, Inc. (The) by 18.5% in the first quarter. YorkBridge Wealth Partners LLC now owns 520 shares of the medical device company’s stock worth $105,000 after buying an additional 81 shares during the last quarter. Penserra Capital Management LLC boosted its stake in shares of Cooper Companies, Inc. (The) by 9.5% in the first quarter. Penserra Capital Management LLC now owns 782 shares of the medical device company’s stock worth $156,000 after buying an additional 68 shares during the last quarter. Pacer Advisors Inc. boosted its stake in shares of Cooper Companies, Inc. (The) by 3.8% in the first quarter. Pacer Advisors Inc. now owns 848 shares of the medical device company’s stock worth $170,000 after buying an additional 31 shares during the last quarter. Dai Ichi Life Insurance Company Ltd purchased a new stake in shares of Cooper Companies, Inc. (The) during the first quarter worth about $206,000. Finally, First Bank & Trust boosted its stake in shares of Cooper Companies, Inc. (The) by 3.6% in the first quarter. First Bank & Trust now owns 1,056 shares of the medical device company’s stock worth $211,000 after buying an additional 37 shares during the last quarter. 98.09% of the stock is owned by institutional investors.

Shares of Cooper Companies, Inc. (NYSE:COO) traded up 0.21% during trading on Thursday, reaching $244.78. 260,677 shares of the company were exchanged. The stock has a market capitalization of $11.96 billion, a PE ratio of 36.70 and a beta of 0.61. Cooper Companies, Inc. has a one year low of $158.73 and a one year high of $256.39. The stock has a 50-day moving average price of $244.79 and a 200-day moving average price of $212.04.

Cooper Companies, Inc. (The) (NYSE:COO) last posted its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, topping the consensus estimate of $2.25 by $0.25. The company had revenue of $522.40 million during the quarter, compared to analyst estimates of $520.71 million. Cooper Companies, Inc. (The) had a net margin of 16.02% and a return on equity of 15.88%. Cooper Companies, Inc. (The)’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.05 earnings per share. Analysts forecast that Cooper Companies, Inc. will post $9.63 EPS for the current year.

The company also recently disclosed a semiannual dividend, which will be paid on Monday, August 7th. Investors of record on Friday, July 21st will be issued a $0.03 dividend. The ex-dividend date of this dividend is Wednesday, July 19th. This represents a dividend yield of 0.02%. Cooper Companies, Inc. (The)’s payout ratio is currently 0.90%.

ILLEGAL ACTIVITY NOTICE: “Bank of America Corp DE Sells 6,897 Shares of Cooper Companies, Inc. (The) (COO)” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/08/03/bank-of-america-corp-de-sells-6897-shares-of-cooper-companies-inc-the-coo-updated-updated-updated.html.

Several research firms have weighed in on COO. Oppenheimer Holdings, Inc. set a $225.00 price target on shares of Cooper Companies, Inc. (The) and gave the company a “hold” rating in a report on Saturday, June 3rd. BidaskClub lowered shares of Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Piper Jaffray Companies raised their price target on shares of Cooper Companies, Inc. (The) to $265.00 and gave the company an “overweight” rating in a research note on Wednesday, July 19th. BMO Capital Markets reaffirmed a “buy” rating and set a $255.00 price target on shares of Cooper Companies, Inc. (The) in a research note on Thursday, July 13th. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies, Inc. (The) in a research note on Friday, July 21st. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $242.00.

In other news, EVP Carol R. Kaufman sold 5,408 shares of the company’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $240.86, for a total transaction of $1,302,570.88. Following the transaction, the executive vice president now owns 49,327 shares in the company, valued at $11,880,901.22. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Paul L. Remmell sold 9,294 shares of the company’s stock in a transaction dated Friday, July 14th. The shares were sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the transaction, the chief executive officer now owns 6,186 shares in the company, valued at approximately $1,536,973.56. The disclosure for this sale can be found here. Insiders sold 67,331 shares of company stock valued at $16,400,454 over the last quarter. 1.60% of the stock is currently owned by corporate insiders.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.